Archives of Women's Mental Health · Nov 19, 2026
The impact of anxiety on menopausal symptom severity: findings from a second-order confirmatory factor analysis
By Hoseinzadeh F, Esmaily H, Saki A
Background Anxiety disorders are prevalent and contribute substantially to the global burden of disease. During the menopausal transition, women may experience anxiety and depressive mood alongside menopausal symptoms. This study evaluated a hypothesized model of the associations between anxiety, depressive mood, and menopausal symptom severity. Materials and methods This cross-sectional study, conducted in Mashhad, Iran, assessed menopausal symptom severity using the validated Iranian version of the MSSI-38 questionnaire in 664 premenopausal, perimenopausal, and postmenopausal women. The analysis examined direct and indirect associations, with depressive mood specified as a potential mediator. Results Among all participants, 246 (37.0%) experienced relatively severe anxiety symptoms, while 172 (25.9%) experienced relatively severe depressive mood symptoms. In the first-order confirmatory factor analysis (CFA) model, the goodness-of-fit indices were CFI = 0.895, TLI = 0.879, and RMSEA = 0.055. Model 3, the adjusted second-order CFA model, showed CFI = 0.958, TLI = 0.953, and RMSEA = 0.034. These findings support associations between anxiety, depressive mood, and menopausal symptom severity. Life events, underlying disease, adequate income, marital status, and physical activity were among the factors associated with menopausal symptom severity. Conclusion This study identified associations between anxiety, depressive mood, and menopausal symptom severity. Considering anxiety and depressive mood may be relevant to the assessment and management of menopausal symptoms; however, the cross-sectional design does not establish temporal or causal relationships.
doi.org/10.1007/s00737-026-01790-3PubMed 43052558Populations